Search all trials

Find therapies in clinical trials near you – page 66

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 961
countries: 28
conditions: 2 103

3 961 trials recruiting28 European countries2 103 conditions coveredUpdated today

Quick filters

Dermatomyositis

Not recruiting

Investigational

Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Glpg3667 Fumarate

Contact Research Centre

Colitis ulcerative

Not recruiting

Investigational

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Obefazimod

Contact Research Centre

Neoplasm malignant

Not recruiting

InvestigationalNo placebo

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

InvestigationalNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Darolutamide

Contact Research Centre

Portal hypertension

Not recruiting

Registered drugNo placebo

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Bi 685509

Contact Research Centre

Tourette's disorder

Not recruiting

Investigational

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Investigational

Romania

Participants:0–17 years · 18–64 years
Substances:Ecopipam Hydrochloride

Contact Research Centre

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Not recruiting

Registered drugNo placebo

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Risankizumab

Contact Research Centre

Bladder cancer

Not recruiting

Registered drug

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Cisplatin

Contact Research Centre

Schizophrenia

Not recruiting

Investigational

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Investigational

Romania

Participants:18–64 years · 65+ years
Substances:Valbenazine Ditosylate

Contact Research Centre

Hepatocellular carcinoma

Not recruiting

Registered drugNo placebo

Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Nivolumab

Contact Research Centre

Cardiovascular disorder

Not recruiting

Registered drug

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Registered drug

Romania

Participants:18–64 years · 65+ years
Substances:Acetylsalicylic Acid

Contact Research Centre

Small cell lung cancer recurrent

Not recruiting

Registered drugNo placebo

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Registered drugNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:Ammonium Chloride

Contact Research Centre

Dermatitis atopic

Not recruiting

Investigational

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Investigational

Romania

Participants:0–17 years · 18–64 years · 65+ years
Substances:Upadacitinib

Contact Research Centre

Find therapies in clinical trials near you – page 66

826 trials match your criteria

Dermatomyositis

Study on the Effects of GLPG3667 for Adults with Dermatomyositis

Colitis ulcerative

Study on the Effects of Obefazimod for Patients with Moderate to Severe Ulcerative Colitis

Neoplasm malignant

Continued Darolutamide Treatment for Cancer Patients from Previous Bayer Studies

Portal hypertension

Study on BI 685509 and Empagliflozin for Patients with Portal Hypertension in Compensated Cirrhosis

Tourette's disorder

Study on the Effects of Ecopipam Hydrochloride for Children and Adolescents with Tourette's Disorder

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Study Comparing Risankizumab and Ustekinumab for Adults with Moderate to Severe Crohn's Disease After Anti-TNF Therapy Failure

Bladder cancer

Study of Pembrolizumab with Chemoradiotherapy for Patients with Muscle-Invasive Bladder Cancer

Schizophrenia

Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

Hepatocellular carcinoma

Study of Relatlimab and Nivolumab for Patients with Advanced Liver Cancer Who Have Not Received Immunotherapy After Tyrosine Kinase Inhibitor Treatment

Cardiovascular disorder

Study on Milvexian for Preventing Stroke in Patients with Acute Ischemic Stroke or High-Risk Transient Ischemic Attack

Small cell lung cancer recurrent

Study comparing tarlatamab with topotecan in patients with relapsed small cell lung cancer after first-line chemotherapy

Dermatitis atopic

Study of Upadacitinib for Adolescents and Adults with Moderate to Severe Eczema

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.